Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Oregovomab

Oregovomab ▴ Oregovomab is an immunotherapeutic murine monoclonal antibody with high affinity for the ovarian tumor-associated antigen, cancer 125 (CA125). This antigen is present in the circulation and on the tumors of a large proportion of patients with ovarian cancer. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cancer Springer Journals

Loading next page...
 
/lp/springer-journals/oregovomab-u4fKCFi7Z3
Publisher
Springer Journals
Copyright
Copyright © 2003 by Adis Data Information BV
Subject
Pharmacy; Pharmacy
ISSN
1175-6357
DOI
10.2165/00024669-200302020-00005
Publisher site
See Article on Publisher Site

Abstract

▴ Oregovomab is an immunotherapeutic murine monoclonal antibody with high affinity for the ovarian tumor-associated antigen, cancer 125 (CA125). This antigen is present in the circulation and on the tumors of a large proportion of patients with ovarian cancer.

Journal

American Journal of CancerSpringer Journals

Published: Aug 10, 2012

References